CALCA and migraine disorder: Intravenous infusion of CGRP induces delayed migraine attacks in susceptible individuals, but not in healthy controls, indicating that CGRP amplifies downstream signaling cascades rather than initiating the migraine itself (Thomsen et al., 1994; Amin et al., 2013).